Recruiting
Phase 1

Phase I Study of Tumor Treating Fields (TTF) in Combination with Cabozantinib or with Pembrolizumab and Nab-Paclitaxel in Patients with Advanced Solid Tumors Involving the Abdomen or Thorax

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT05092373

Conditions

Advanced Breast Carcinoma

Advanced Endometrial Carcinoma

Advanced Fallopian Tube Carcinoma

Advanced Hepatocellular Carcinoma

Advanced Malignant Abdominal Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Atezolizumab

Cabozantinib S-malate

Nab-paclitaxel

Tumor Treating Fields Therapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information